GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Health Industries Holdings Inc (OTCPK:CHHE) » Definitions » 3-Year Revenue Growth Rate

China Health Industries Holdings (China Health Industries Holdings) 3-Year Revenue Growth Rate : -76.40% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is China Health Industries Holdings 3-Year Revenue Growth Rate?

China Health Industries Holdings's Revenue per Share for the three months ended in Dec. 2023 was $0.00.

During the past 12 months, China Health Industries Holdings's average Revenue per Share Growth Rate was 100.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -76.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of China Health Industries Holdings was 75.20% per year. The lowest was -76.40% per year. And the median was -14.90% per year.


Competitive Comparison of China Health Industries Holdings's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Industries Holdings's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where China Health Industries Holdings's 3-Year Revenue Growth Rate falls into.



China Health Industries Holdings 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


China Health Industries Holdings  (OTCPK:CHHE) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


China Health Industries Holdings 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of China Health Industries Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


China Health Industries Holdings (China Health Industries Holdings) Business Description

Traded in Other Exchanges
N/A
Address
3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028
China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
Executives
Sun Xin director, 10 percent owner, officer: CEO, CFO and Treasurer NO 168 BINBEI STREET, SONBEI DISTRICT, HARBIN, HEI LONG JIANG F4 150000
Hall E Ewing director, officer: Secretary 2737 W BASELINE RD 22, TEMPE AZ 85283
Jack C Robinson director 16304 E COUNTRY SHADOW CT, LILBEAT AZ 85297
Teri S Foster director 402 CANDOVER COURT, KATY TX 77450
Brian Lee Hahn director, officer: COO 422 LAMONT TERRACE, BUFFALO GROVE IL 60089
Dennis Mckee 10 percent owner 3522 DOHERTY PLACE, KATY TX 77449
Thomas Allen Bontems 10 percent owner, officer: President, CEO, CFO and, other: Secretary 1808 S. 1ST AVENUE, PHONEIX AZ 85003

China Health Industries Holdings (China Health Industries Holdings) Headlines

No Headlines